Comparison

Rasagiline European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 200mg
Item no. TMO-T1119-200mg
Targets BCR
CASRN 136236-51-6
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Rasagiline is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease.
Shipping
cool pack
Storage
-20°
Target names or alias
TVP1012 , AGN1135
Molecular Weight
171, 24
Pathway
Metabolism|||Apoptosis|||Neuroscience
Target
Monoamine Oxidase|||BCL|||MAO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close